Does lululemon Athletica Inc. (NASDAQ: LULU) really feel like Under Armour Inc. (NYSE: UA)? The long and short of it is "NO, it doesn't." But there are many merits ahead, and the underlying "sport" of yoga has actually continued to grow in appeal to the masses. Yoga, it seems, isn't just for hippies anymore.
On Friday evening's MAD MONEY on CNBC, Jim Cramer noted that Lululemon has many of the same characteristics of Under Armour. In his defense, this was more figurative than literal and he said there is not a hurry to buy it because it has run a lot already. The company has many store openings and even more coming in 2008, and Cramer is looking at it for accelerated revenue and accelerated earnings growth.
LULU is an odd call because there are actually very few reliable statistics on just how many people practice yoga. Many still believe that it's a bit strange or "out there," compared to other forms of exercise or stress-relief. When you look at the lululemon.com website you will understand why. If you have ever taken a yoga class, you will know why the stereotypes can instantly be debunked. LULU is going to be interesting to watch, mainly because of its stellar IPO performance. Cramer recently called Under Armour "The Next Nike!" but that won't be the case for LULU. Still, there is a growth story here, and one that investors are looking at. How it will do and if it manages its own growth is where the jury is still out.
Last updated: February 12, 2012: 10:39 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- Milestone Aviation Group signs contract for three S-92 helicopters
- Greek parliament approves austerity bill, Reuters reports
- Xstrata shareholders want Glencore offer above three shares, Telegraph says
- France Telecom pursuing greater interest in Egypt's Mobinil, Bloomberg says
- Arab league to ask U.N. for a peacekeeping force in Syria, WSJ says
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger


Reader Comments (Page 1 of 1)
8-06-2007 @ 5:05PM
mbf6b said...
Obvious potential for store openings at lulu but comp store performance will suffer in the process. Their $1600 sales/sqft figures are somewhat based on the fact they only have 1 store in some geographic regions, this will have to change as they look to expand. Sure, they may see 50% overall growth over the next few years due to new store openings, but comp store growth won't follow suit, and that will be the downfall of lulu.